Product image of Yuflyma (Adalimumab) supplied by GNH India

Yuflyma

Active Ingredient:
Adalimumab
Origin:
EU

Yuflyma (Adalimumab)

Yuflyma (Adalimumab) is a biologic medication used for autoimmune conditions like rheumatoid arthritis and psoriasis. This EU-sourced subcutaneous injection offers targeted immune system support. Always consult a healthcare provider for personalized guidance.

Manufacturer / TM Owner

Celltrion Healthcare Hungary Kft

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Yuflyma is commonly used to reduce inflammation and manage symptoms in autoimmune disorders such as rheumatoid arthritis, psoriatic arthritis, and plaque psoriasis. It may also be prescribed for ankylosing spondylitis and Crohn’s disease. This medication helps relieve joint pain, swelling, and skin plaques by targeting specific immune pathways. Patients often use it when other treatments have not provided sufficient relief.

Side Effects

  • Many users report improved mobility and reduced discomfort after starting Yuflyma, as it works to calm overactive immune responses. Skin improvements, such as clearer patches and reduced scaling, are commonly noted in psoriasis patients. Some individuals experience a gradual reduction in symptoms over weeks of consistent use.

Precautions & Warnings

  • Store Yuflyma in the refrigerator until ready to use and protect it from light. Keep the medication out of reach of children and pets. Do not use if the liquid is discolored or contains particles. Dispose of used needles safely in a sharps container. Always follow local guidelines for biologic medication disposal.

Avoid Interactions

  • Yuflyma may interact with live vaccines, increasing infection risk, so avoid vaccinations during treatment without consulting a doctor. Combining it with other immunosuppressants could heighten infection susceptibility. Alcohol use may exacerbate side effects like dizziness or nausea. Always inform healthcare providers about all medications and supplements being taken.

Frequently Asked Questions

Yuflyma is used to treat autoimmune conditions like rheumatoid arthritis, psoriasis, and Crohn’s disease by reducing inflammation.

Yuflyma is given as a subcutaneous injection, typically under the skin of the thigh or abdomen.

Yuflyma may be available through licensed online pharmacies with a valid prescription.

Common side effects include injection site reactions, headaches, and mild infections like colds.

Pregnancy use should be discussed with a healthcare provider to weigh risks and benefits.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Adalimumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT